Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Cash Flow Reinvestment Rate
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Cash Flow Reinvestment Rate of 3.98x as of December 2024, reinvesting CN¥503.43 Million (capex CN¥115.96 Million plus investments CN¥-387.47 Million) from operating cash flow of CN¥126.49 Million. Check earnings quality score of Jiangsu Canopus Wisdom Medical Technolog to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A across 5 annual periods. Explore 301290 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Year-by-year capital reinvestment analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A. For live market cap and broader valuation context, see 301290 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.98x | CN¥503.43 Million | CN¥126.49 Million | CN¥115.96 Million | ▲ +2.0% |
| 2023 | 3.90x | CN¥636.51 Million | CN¥163.13 Million | CN¥111.46 Million | ▲ +162.4% |
| 2022 | 1.49x | CN¥140.72 Million | CN¥94.63 Million | CN¥74.35 Million | ▲ +142.4% |
| 2021 | 0.61x | CN¥100.25 Million | CN¥163.45 Million | CN¥95.67 Million | ▼ -76.8% |
| 2020 | 2.64x | CN¥301.35 Million | CN¥114.07 Million | CN¥25.43 Million | — |